$32.81
4.57% yesterday
Nasdaq, Apr 25, 10:00 pm CET
ISIN
US80706P1030
Symbol
SRRK
Sector
Industry

Scholar Rock Holding Corp. Stock price

$32.81
-0.47 1.41% 1M
+2.90 9.70% 6M
-10.41 24.09% YTD
+18.85 135.03% 1Y
+23.90 268.24% 3Y
+15.17 86.00% 5Y
+17.31 111.68% 10Y
Nasdaq, Closing price Fri, Apr 25 2025
-1.57 4.57%
ISIN
US80706P1030
Symbol
SRRK
Sector
Industry

Key metrics

Market capitalization $3.11b
Enterprise Value $2.74b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
P/B ratio (TTM) P/B ratio 8.35
Revenue (TTM) Revenue $0.00
EBIT (operating result TTM) EBIT $-252.05m
Free Cash Flow (TTM) Free Cash Flow $-201.05m
Cash position $437.28m
EPS (TTM) EPS $-2.57
P/E forward negative
P/S forward 117.61
EV/Sales forward 103.55
Short interest 31.52%
Show more

Is Scholar Rock Holding Corp. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,790 stocks worldwide.

Scholar Rock Holding Corp. Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Scholar Rock Holding Corp. forecast:

9x Buy
100%

Analyst Opinions

9 Analysts have issued a Scholar Rock Holding Corp. forecast:

Buy
100%

Financial data from Scholar Rock Holding Corp.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
- -
-
100%
- Direct Costs 1.94 1.94
70% 70%
-
-1.94 -1.94
70% 70%
-
- Selling and Administrative Expenses 66 66
53% 53%
-
- Research and Development Expense 183 183
58% 58%
-
-250 -250
52% 52%
-
- Depreciation and Amortization 1.94 1.94
70% 70%
-
EBIT (Operating Income) EBIT -252 -252
47% 47%
-
Net Profit -246 -246
49% 49%
-

In millions USD.

Don't miss a Thing! We will send you all news about Scholar Rock Holding Corp. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Scholar Rock Holding Corp. Stock News

Positive
The Motley Fool
2 days ago
Biotech stock Scholar Rock (SRRK 2.97%) was popular among investors on Wednesday after a positive new analyst note on the company made the rounds. This resulted in the stock bumping nearly 3% higher on the day.
Neutral
Business Wire
7 days ago
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK; the “Company”), a late-stage biopharmaceutical company focused on advancing innovative treatments for neuromuscular diseases, cardiometabolic disorders, and other serious diseases, today announced that the company granted inducement equity awards covering an aggregate of 156,650 shares of its common stock to 19 newly hired employees...
Neutral
Business Wire
about one month ago
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for neuromuscular diseases, cardiometabolic disorders, and other serious diseases, today announced that the U.S. Food and Drug Administration (FDA) has accepted its Biologics License Application (BLA) for apitegromab, an investigational muscle-targete...
More Scholar Rock Holding Corp. News

Company Profile

Scholar Rock Holding Corp. is a biopharmaceutical company. It engages in the development and discovery of innovative medicines. The company offers proprietary platform which designed to discover and develop monoclonal antibodies that have a high degree of specificity to achieve selective modulation of growth factor signaling. Its product candidate includes SRK-015 and SRK-181. The company was founded by Timothy A. Springer and Leonard I. Zon in October 2012 and is headquartered in Cambridge, MA.

Head office United States
CEO Jay Backstrom
Employees 196
Founded 2012
Website www.scholarrock.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today